Since raising our first Opportunity Fund in 2009, we have focused on a special situations strategy of investing.
We operate differently from traditional venture funds in that we provide late-stage medical device and diagnostic companies with creative financing solutions that address both their capital needs and syndicate risk.
We believe our strategy provides a superior risk/return profile versus traditional venture structures, as evidenced by our performance to date.
SightLine Partners seeks to invest in and assist high-quality companies in the MedTech space, while stabilizing syndicates, and driving superior returns for its investors.
8500 Normandale Lake Blvd., Suite 1070
55437 United States